Noah Berkowitz
CIK 1369900 · Chief Medical Officer · last filed 2026-05-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.54M
Companies
3
Total Filings
25
Lifetime Open-Market Net
-$323.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 3
25 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-18 | ARVN | Notice (144) | −8,658 | -$74.4K | EDGAR |
| 2025-02-18 | ARVN | Grant (A) | +55,229 | $0 | EDGAR |
| 2024-03-21 | ARVN | Grant (A) | +63,452 | $0 | EDGAR |
| 2008-12-03 | Synvista Therapeutics, Inc. (SYI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-07-24 | Synvista Therapeutics, Inc. (SYI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-11-21 | Synvista Therapeutics, Inc. (SYI) Delisted | Disp (D) | −3,000 | -$7.2K | EDGAR |
| 2007-11-02 | Synvista Therapeutics, Inc. (SYI) Delisted | Disp (D) | −4,000 | -$10.0K | EDGAR |
| 2007-10-22 | Synvista Therapeutics, Inc. (SYI) Delisted | Disp (D) | −3,000 | -$7.5K | EDGAR |
| 2007-10-05 | Synvista Therapeutics, Inc. (SYI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-10-03 | Synvista Therapeutics, Inc. (SYI) Delisted | Disp (D) | −4,000 | -$11.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.